Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TP53 | P04637 | 5/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.44 |
| ▸ | HPGD | P15428 | 6/20 | 0.43 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.43 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.43 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.43 |
| ▸ | ROCK2 | O75116 | 1/20 | 0.42 |
| ▸ | ROCK1 | Q13464 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 4/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | HTT | P42858 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
| ▸ | ATM | Q13315 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6703136 | 0.86 | TP53 (0.47) | TP53LMNATDP1HPGDMAPK1 | |
| SCHEMBL6702887 | 0.85 | MAPK1 (0.49) | TP53LMNATDP1HPGDMAPK1 | |
| SCHEMBL6694919 | 0.85 | TP53 (0.53) | TP53LMNATDP1HPGDMAPK1 | |
| SCHEMBL6664832 | 0.85 | TP53 (0.54) | TP53LMNATDP1HPGDMAPK1 | |
| SCHEMBL6694288 | 0.84 | TP53 (0.51) | TP53TDP1HPGDMAPK1ALDH1A1 | |
| SCHEMBL6664702 | 0.82 | TP53 (0.54) | TP53LMNATDP1HPGDMEN1 | |
| SCHEMBL6699272 | 0.82 | TP53 (0.51) | TP53LMNATDP1MAPK1MEN1 | |
| SCHEMBL6702873 | 0.81 | TP53 (0.47) | TP53LMNATDP1HPGDMAPK1 | |
| SCHEMBL6703840 | 0.79 | TP53 (0.53) | TP53LMNATDP1MAPK1 | |
| SCHEMBL5952814 | 0.77 | FLT3 (0.55) | MAPK1ROCK2ROCK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1441725-A1 | BENZIMIDAZOLES AND ANALOGUES AND THEIR USE AS PROTEIN KINASES INHIBITORS | Aventis Pharmaceuticals Inc. (US) | 2004-08-04 | — | — | EP | claimed |
| WO-2003035065-A1 | BENZIMIDAZOLES AND ANALOGUES AND THEIR USE AS PROTEIN KINASES INHIBITORS | AVENTIS PHARMACEUTICALS INC (US) | 2003-05-01 | — | — | WO | claimed |